Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption

Linda M. Liau, Roger L. Lallone, Robert S. Seitz, Alexei Buznikov, Jeffrey Gregg, Harley I. Kornblurn, Stanley F. Nelson, Jeff M. Bronstein

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Identification of the genes that are differentially expressed in brain tumor cells but not in normal brain cells is important for understanding the molecular basis of these neurological cancers and for defining possible targets for therapeutic intervention. In an effort to discover potentially antigenic proteins that may be involved in the malignant transformation and progression of human glioblastomas, a novel antibody-based approach was developed to identify and isolate gene products that are expressed in brain tumors versus normal brain tissue. Using this method, whereby tumor-specific antibodies were isolated and used to screen a glioblastoma cDNA expression library, 28 gene products were identified. Nine of these clones had homology to known gene products, and 19 were novel. The expression of these genes in multiple different human gliomas was then evaluated by cDNA microarray hybridization. One of the isolated clones had consistently higher levels of expression (3-30-fold) in brain tumors compared with normal brain. Northern blot analysis and in situ hybridization confirmed this differential overexpression. cDNA sequence analysis revealed that this gene was identical to a relatively new class of growth regulators known as granulins, which have tertiary structures resembling the epidermal growth factor-like proteins. The 2.1-kb granulin mRNA was expressed predominantly in glial tumors, with lower levels in spleen, kidney, and testes, whereas expression was not detected in non-tumor brain tissues. Functional assays using [3H]thymidine incorporation indicated that granulin may be a glial mitogen, as addition of synthetic granulin peptide to primary rat astrocytes and three different early-passage human glioblastoma cultures increased cell proliferation in vitro, whereas increasing concentrations of granulin antibody inhibited cell growth in a dose-dependent manner. The differential expression pattern, tissue distribution, and implication of this glioma-associated molecule in growth regulation suggest a potentially important role for granulin in the pathogenesis and/or malignant progression of primary brain neoplasms.

Original languageEnglish (US)
Pages (from-to)1353-1360
Number of pages8
JournalCancer Research
Volume60
Issue number5
StatePublished - Mar 1 2000

Fingerprint

Forensic Anthropology
Glioma
Intercellular Signaling Peptides and Proteins
Brain Neoplasms
Glioblastoma
Genes
Brain
Neuroglia
Growth
Clone Cells
Neoplasm Antibodies
Antibodies
Tissue Distribution
Oligonucleotide Array Sequence Analysis
Gene Library
Mitogens
Astrocytes
Northern Blotting
Thymidine
In Situ Hybridization

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Liau, L. M., Lallone, R. L., Seitz, R. S., Buznikov, A., Gregg, J., Kornblurn, H. I., ... Bronstein, J. M. (2000). Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Research, 60(5), 1353-1360.

Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. / Liau, Linda M.; Lallone, Roger L.; Seitz, Robert S.; Buznikov, Alexei; Gregg, Jeffrey; Kornblurn, Harley I.; Nelson, Stanley F.; Bronstein, Jeff M.

In: Cancer Research, Vol. 60, No. 5, 01.03.2000, p. 1353-1360.

Research output: Contribution to journalArticle

Liau, LM, Lallone, RL, Seitz, RS, Buznikov, A, Gregg, J, Kornblurn, HI, Nelson, SF & Bronstein, JM 2000, 'Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption', Cancer Research, vol. 60, no. 5, pp. 1353-1360.
Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg J, Kornblurn HI et al. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Research. 2000 Mar 1;60(5):1353-1360.
Liau, Linda M. ; Lallone, Roger L. ; Seitz, Robert S. ; Buznikov, Alexei ; Gregg, Jeffrey ; Kornblurn, Harley I. ; Nelson, Stanley F. ; Bronstein, Jeff M. / Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. In: Cancer Research. 2000 ; Vol. 60, No. 5. pp. 1353-1360.
@article{6e49ff3d3cc54dab9ff6c94f29569270,
title = "Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption",
abstract = "Identification of the genes that are differentially expressed in brain tumor cells but not in normal brain cells is important for understanding the molecular basis of these neurological cancers and for defining possible targets for therapeutic intervention. In an effort to discover potentially antigenic proteins that may be involved in the malignant transformation and progression of human glioblastomas, a novel antibody-based approach was developed to identify and isolate gene products that are expressed in brain tumors versus normal brain tissue. Using this method, whereby tumor-specific antibodies were isolated and used to screen a glioblastoma cDNA expression library, 28 gene products were identified. Nine of these clones had homology to known gene products, and 19 were novel. The expression of these genes in multiple different human gliomas was then evaluated by cDNA microarray hybridization. One of the isolated clones had consistently higher levels of expression (3-30-fold) in brain tumors compared with normal brain. Northern blot analysis and in situ hybridization confirmed this differential overexpression. cDNA sequence analysis revealed that this gene was identical to a relatively new class of growth regulators known as granulins, which have tertiary structures resembling the epidermal growth factor-like proteins. The 2.1-kb granulin mRNA was expressed predominantly in glial tumors, with lower levels in spleen, kidney, and testes, whereas expression was not detected in non-tumor brain tissues. Functional assays using [3H]thymidine incorporation indicated that granulin may be a glial mitogen, as addition of synthetic granulin peptide to primary rat astrocytes and three different early-passage human glioblastoma cultures increased cell proliferation in vitro, whereas increasing concentrations of granulin antibody inhibited cell growth in a dose-dependent manner. The differential expression pattern, tissue distribution, and implication of this glioma-associated molecule in growth regulation suggest a potentially important role for granulin in the pathogenesis and/or malignant progression of primary brain neoplasms.",
author = "Liau, {Linda M.} and Lallone, {Roger L.} and Seitz, {Robert S.} and Alexei Buznikov and Jeffrey Gregg and Kornblurn, {Harley I.} and Nelson, {Stanley F.} and Bronstein, {Jeff M.}",
year = "2000",
month = "3",
day = "1",
language = "English (US)",
volume = "60",
pages = "1353--1360",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption

AU - Liau, Linda M.

AU - Lallone, Roger L.

AU - Seitz, Robert S.

AU - Buznikov, Alexei

AU - Gregg, Jeffrey

AU - Kornblurn, Harley I.

AU - Nelson, Stanley F.

AU - Bronstein, Jeff M.

PY - 2000/3/1

Y1 - 2000/3/1

N2 - Identification of the genes that are differentially expressed in brain tumor cells but not in normal brain cells is important for understanding the molecular basis of these neurological cancers and for defining possible targets for therapeutic intervention. In an effort to discover potentially antigenic proteins that may be involved in the malignant transformation and progression of human glioblastomas, a novel antibody-based approach was developed to identify and isolate gene products that are expressed in brain tumors versus normal brain tissue. Using this method, whereby tumor-specific antibodies were isolated and used to screen a glioblastoma cDNA expression library, 28 gene products were identified. Nine of these clones had homology to known gene products, and 19 were novel. The expression of these genes in multiple different human gliomas was then evaluated by cDNA microarray hybridization. One of the isolated clones had consistently higher levels of expression (3-30-fold) in brain tumors compared with normal brain. Northern blot analysis and in situ hybridization confirmed this differential overexpression. cDNA sequence analysis revealed that this gene was identical to a relatively new class of growth regulators known as granulins, which have tertiary structures resembling the epidermal growth factor-like proteins. The 2.1-kb granulin mRNA was expressed predominantly in glial tumors, with lower levels in spleen, kidney, and testes, whereas expression was not detected in non-tumor brain tissues. Functional assays using [3H]thymidine incorporation indicated that granulin may be a glial mitogen, as addition of synthetic granulin peptide to primary rat astrocytes and three different early-passage human glioblastoma cultures increased cell proliferation in vitro, whereas increasing concentrations of granulin antibody inhibited cell growth in a dose-dependent manner. The differential expression pattern, tissue distribution, and implication of this glioma-associated molecule in growth regulation suggest a potentially important role for granulin in the pathogenesis and/or malignant progression of primary brain neoplasms.

AB - Identification of the genes that are differentially expressed in brain tumor cells but not in normal brain cells is important for understanding the molecular basis of these neurological cancers and for defining possible targets for therapeutic intervention. In an effort to discover potentially antigenic proteins that may be involved in the malignant transformation and progression of human glioblastomas, a novel antibody-based approach was developed to identify and isolate gene products that are expressed in brain tumors versus normal brain tissue. Using this method, whereby tumor-specific antibodies were isolated and used to screen a glioblastoma cDNA expression library, 28 gene products were identified. Nine of these clones had homology to known gene products, and 19 were novel. The expression of these genes in multiple different human gliomas was then evaluated by cDNA microarray hybridization. One of the isolated clones had consistently higher levels of expression (3-30-fold) in brain tumors compared with normal brain. Northern blot analysis and in situ hybridization confirmed this differential overexpression. cDNA sequence analysis revealed that this gene was identical to a relatively new class of growth regulators known as granulins, which have tertiary structures resembling the epidermal growth factor-like proteins. The 2.1-kb granulin mRNA was expressed predominantly in glial tumors, with lower levels in spleen, kidney, and testes, whereas expression was not detected in non-tumor brain tissues. Functional assays using [3H]thymidine incorporation indicated that granulin may be a glial mitogen, as addition of synthetic granulin peptide to primary rat astrocytes and three different early-passage human glioblastoma cultures increased cell proliferation in vitro, whereas increasing concentrations of granulin antibody inhibited cell growth in a dose-dependent manner. The differential expression pattern, tissue distribution, and implication of this glioma-associated molecule in growth regulation suggest a potentially important role for granulin in the pathogenesis and/or malignant progression of primary brain neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=0034163549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034163549&partnerID=8YFLogxK

M3 - Article

C2 - 10728698

AN - SCOPUS:0034163549

VL - 60

SP - 1353

EP - 1360

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 5

ER -